Inge Verberk
0000-0003-0341-7445
Academic Medical Center
14 papers found
Refreshing results…
Fully automated measurement of plasma Aβ42/40 and p‐tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts
Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults
Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline
Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in Multiple Sclerosis
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
Reply to “Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population”
Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy
Serum Neurofilament light correlates with CADASIL disease severity and survival
Plasma Amyloid as Prescreener for the Earliest A lzheimer Pathological Changes
Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis
Missing publications? Search for publications with a matching author name.